Achilles
is an England-based biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer... Read moreAchilles
is an England-based biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer... Read more
News
Dec 24, 2024
Benzinga
Achilles: Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts
Dec 24, 2024
StreetInsider
Press Release: Achilles : Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
Dec 24, 2024
Benzinga
Achilles: Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
Nov 19, 2024
centralcharts
Press Release: Achilles : Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
Sep 19, 2024
FinanzNachrichten
Achilles: Achilles Therapeutics PLC: Achilles Therapeutics Announces Strategic Update
Sep 19, 2024
Benzinga
Achilles: Achilles Therapeutics Shares Are Trading Higher: What You Need To Know
Aug 05, 2024
MarketScreener
Achilles: Achilles Therapeutics : Information Contained in this Report on Form 6 K Form 6 K
Jun 27, 2024
MarketScreener
Achilles: Achilles Therapeutics : Results of Annual General Meeting Form 6 K
May 22, 2024
FinanzNachrichten
Achilles: Achilles Therapeutics PLC: Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
May 17, 2024
BioSpace
Achilles: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - May 17, 2024
Achilles Competitors
1
2
3
4
5
6
7
8